Literature DB >> 23769969

A case with combined rare inborn metabolic disorders: congenital adrenal hyperplasia and ornithine transcarbamylase deficiency.

Yoo-Mi Kim1, Beom Hee Lee, Jin-Ho Choi, Gu-Hwan Kim, Han Hyuk Lim, Han-Wook Yoo.   

Abstract

Congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency is a common autosomal recessive disorder. Ornithine transcarbamylase (OTC) deficiency is the most common urea cycle disorder and demonstrates X-linked inheritance. In female OTC deficiency, phenotypes are variable according to X-inactivation patterns. These disorders develop separately, and their co-morbidity is extremely rare. We report one girl with CAH showing recurrent hyperammonemia and hepatitis after 2 years-of-age due to additional OTC deficiency.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  17-Hydroxyprogesterone; 17-OHP; 21-Hydroxylase deficient congenital adrenal hyperplasia; CAH; Co-morbidity; OTC; Ornithine transcarbamylase deficiency; Urea cycle disorder; congenital adrenal hyperplasia; ornithine transcarbamylase

Mesh:

Substances:

Year:  2013        PMID: 23769969     DOI: 10.1016/j.gene.2013.03.096

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  2 in total

1.  Clinical outcomes and the mutation spectrum of the OTC gene in patients with ornithine transcarbamylase deficiency.

Authors:  Jin-Ho Choi; Beom Hee Lee; Ja Hye Kim; Gu-Hwan Kim; Yoo-Mi Kim; Jahyang Cho; Chong-Kun Cheon; Jung Min Ko; Jung Hyun Lee; Han-Wook Yoo
Journal:  J Hum Genet       Date:  2015-09       Impact factor: 3.172

2.  A case of combined 21-hydroxylase deficiency and CHARGE syndrome featuring micropenis and cryptorchidism.

Authors:  Satoko Umino; Miyuki Kitamura; Yuko Katoh-Fukui; Maki Fukami; Takeshi Usui; Shuichi Yatsuga; Yasutoshi Koga
Journal:  Mol Genet Genomic Med       Date:  2019-05-06       Impact factor: 2.183

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.